How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,447 results for

Intrauterine Growth Retardation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction

EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction (EGEVE) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01490489 Recruitment Status : Unknown Verified February 2015 by Institut National de la Santé Et de la Recherche Médicale, France. Recruitment

2011 Clinical Trials

122. Intrauterine growth restriction affects hippocampal dual specificity phosphatase 5 gene expression and epigenetic characteristics Full Text available with Trip Pro

Intrauterine growth restriction affects hippocampal dual specificity phosphatase 5 gene expression and epigenetic characteristics Intrauterine growth retardation (IUGR) predisposes humans toward hippocampal morbidities, such as impaired learning and memory. Hippocampal dual specificity phosphatase 5 (DUSP5) may be involved in these morbidities because DUSP5 regulates extracellular signal-regulated kinase phosphorylation (Erk). In the rat, IUGR causes postnatal changes in hippocampal gene

2011 Physiological genomics

123. Early screening for pre-eclampsia and intrauterine growth restriction. (Abstract)

Early screening for pre-eclampsia and intrauterine growth restriction. 21520318 2011 06 29 2016 11 25 1469-0705 37 5 2011 May Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology Ultrasound Obstet Gynecol Early screening for pre-eclampsia and intrauterine growth restriction. 623-4 10.1002/uog.9018 Harrington Kevin K eng Journal Article England Ultrasound Obstet Gynecol 9108340 0960-7692 IM Early Diagnosis Female (...) Fetal Growth Retardation diagnostic imaging Humans Mass Screening Placental Circulation Pre-Eclampsia diagnostic imaging Pregnancy Ultrasonography 2011 4 27 6 0 2011 4 27 6 0 2011 6 30 6 0 ppublish 21520318 10.1002/uog.9018

2011 Ultrasound in Obstetrics and Gynecology

124. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis

' gestation. Authors' objectives To assess the influence of gestational age at the time of introduction of low-dose acetylsalicylic acid (ASA) on the incidence of pre-eclampsia and intrauterine growth restriction (IUGR) in women at increased risk on the basis of abnormal uterine artery Doppler. Searching MEDLINE, EMBASE and The Cochrane Library were searched without language restrictions from 1965 to 2008. Search terms were reported. Bibliographies of recent two meta-analyses were handsearched (...) Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler

2009 DARE.

125. Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy

congenital malformations or neonatal diseases Severe concurrent or chronic diseases Intrauterine growth retardation Neonatal infections ( e.g. CMV, HIV) Simultaneous participation in other clinical trials Parents not signing written informed consent Unable to adhere to protocol requirements or study visits due to non compliance of parents or caregivers. Liver, kidney, haematological abnormalities as judged clinically by investigators at baseline. Contacts and Locations Go to Information from the National (...) . Other Names: HRF-1 from 0 to 6 months of age HRF-2 from 6 months of age onwards Placebo Comparator: eHF (Extensive Hydrolysed Formula) Extensive Hydrolysed Cow's Milk Protein Formula (eHF) Other: eHF The subject will take the formula for a period of 12 months. Other Names: eHF-1 from 0 to 6 months of age eHF-2 from 6 months of age onwards Outcome Measures Go to Primary Outcome Measures : Growing change [ Time Frame: 6 months ] To evaluate the children growth using a rice hydrolysed protein formula

2014 Clinical Trials

126. FACTORS ASSOCIATED WITH GROWTH PATTERNS FROM BIRTH TO EIGHTEEN MONTHS IN A BENINESE COHORT OF CHILDREN. (Abstract)

anthropometric measurements taken at delivery, every month up to 6 months and then quarterly. Infant and young child feeding (IYCF) practices and malarial morbidity were recorded. Gestational age was estimated using the Ballard method; William's sex-specific reference curve of birth weight-for-gestational-age was used to determine intrauterine growth retardation (IUGR). Analyses were performed on 520 children using a linear mixed model. Low birth weight (coef=-0.43; p=0.002), IUGR (coef=-0.49; p<0.001 (...) FACTORS ASSOCIATED WITH GROWTH PATTERNS FROM BIRTH TO EIGHTEEN MONTHS IN A BENINESE COHORT OF CHILDREN. The aim of this study was to analyze factors influencing the growth pattern of children from birth to 18 months. A longitudinal prospective study was conducted in three maternity wards in Southern Benin. Inclusion took place between June 2007 and July 2008; children were followed-up until 18 months of age. Height-for-age and weight-for-height Z-scores were computed using the newborn's

2014 Acta Tropica

127. Evaluation of growth in very low birth weight preterm babies Full Text available with Trip Pro

in the neonatal intensive care unit (NICU) of our hospital were examined. The target height formula was used in assessment of growht in height and the contribution of genetic properties was investigated. The points of the subjects on the growth curve were plotted according to the Percentile Curve of the Turkish Children prepared by Neyzi et al. The states of the subjects with and without intrauterine growth retardation (were compared. The study was intitiated after obtaining approval from the ethics (...) Evaluation of growth in very low birth weight preterm babies The aim of this study was to evaluate physical growth of very low birth weight (VLBW) preterm babies at a mean age of three years and to investigate the factors which affected growth.The factors including maternal problems, prenatal problems, early neonatal problems, nutrition, familial socioeconomical status and presence of chronic disease which affected catch-up growth in terms of height and weight in VLBW infants followed up

2014 Turkish Archives of Pediatrics/Türk Pediatri Arşivi

128. Fetal Growth Restriction (Overview)

is necessary. The ability to diagnose the disorder and understand its pathophysiology still outpaces the ability to prevent or treat its complications. The current therapeutic goals are to optimize the timing of delivery to minimize hypoxemia and maximize gestational age and maternal outcome. Further study may elucidate preventive or treatment strategies to assist the growth-restricted fetus. Previous References Severi FM, Rizzo G, Bocchi C, et al. Intrauterine growth retardation and fetal cardiac function (...) retardation and perinatal death? An overview. BJOG . 2000 Feb. 107(2):196-208. . Mandruzzato GP, Bogatti P, Fischer L, Gigli C. The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery. Ultrasound Obstet Gynecol . 1991 May 1. 1(3):192-6. . Fong KW, Ohlsson A, Hannah ME, et al. Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries. Radiology . 1999 Dec

2014 eMedicine.com

129. Fetal Growth Restriction (Treatment)

is necessary. The ability to diagnose the disorder and understand its pathophysiology still outpaces the ability to prevent or treat its complications. The current therapeutic goals are to optimize the timing of delivery to minimize hypoxemia and maximize gestational age and maternal outcome. Further study may elucidate preventive or treatment strategies to assist the growth-restricted fetus. Previous References Severi FM, Rizzo G, Bocchi C, et al. Intrauterine growth retardation and fetal cardiac function (...) retardation and perinatal death? An overview. BJOG . 2000 Feb. 107(2):196-208. . Mandruzzato GP, Bogatti P, Fischer L, Gigli C. The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery. Ultrasound Obstet Gynecol . 1991 May 1. 1(3):192-6. . Fong KW, Ohlsson A, Hannah ME, et al. Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries. Radiology . 1999 Dec

2014 eMedicine.com

130. Fetal Growth Restriction (Follow-up)

is necessary. The ability to diagnose the disorder and understand its pathophysiology still outpaces the ability to prevent or treat its complications. The current therapeutic goals are to optimize the timing of delivery to minimize hypoxemia and maximize gestational age and maternal outcome. Further study may elucidate preventive or treatment strategies to assist the growth-restricted fetus. Previous References Severi FM, Rizzo G, Bocchi C, et al. Intrauterine growth retardation and fetal cardiac function (...) retardation and perinatal death? An overview. BJOG . 2000 Feb. 107(2):196-208. . Mandruzzato GP, Bogatti P, Fischer L, Gigli C. The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery. Ultrasound Obstet Gynecol . 1991 May 1. 1(3):192-6. . Fong KW, Ohlsson A, Hannah ME, et al. Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries. Radiology . 1999 Dec

2014 eMedicine.com

131. Fetal Growth Restriction (Diagnosis)

is necessary. The ability to diagnose the disorder and understand its pathophysiology still outpaces the ability to prevent or treat its complications. The current therapeutic goals are to optimize the timing of delivery to minimize hypoxemia and maximize gestational age and maternal outcome. Further study may elucidate preventive or treatment strategies to assist the growth-restricted fetus. Previous References Severi FM, Rizzo G, Bocchi C, et al. Intrauterine growth retardation and fetal cardiac function (...) retardation and perinatal death? An overview. BJOG . 2000 Feb. 107(2):196-208. . Mandruzzato GP, Bogatti P, Fischer L, Gigli C. The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery. Ultrasound Obstet Gynecol . 1991 May 1. 1(3):192-6. . Fong KW, Ohlsson A, Hannah ME, et al. Prediction of perinatal outcome in fetuses suspected to have intrauterine growth restriction: Doppler US study of fetal cerebral, renal, and umbilical arteries. Radiology . 1999 Dec

2014 eMedicine.com

132. Growth Hormone Deficiency (Overview)

Growth Hormone Deficiency Updated: Aug 22, 2018 Author: Vaneeta Bamba, MD; Chief Editor: Robert P Hoffman, MD Share Email Print Feedback Close Sections Sections Pediatric Growth Hormone Deficiency Overview Practice Essentials Presentation History The history in patients with suspected growth hormone deficiency (GHD) should focus on the following issues: Birth weight and length: Intrauterine growth retardation is an issue in the differential diagnosis and should be apparent from the birth history (...) –releasing peptides (GHRPs). Receptors for the GHRPs have been identified, and the natural ligand for these receptors has been determined to be ghrelin. Somatostatin secreted by the hypothalamus inhibits growth hormone secretion. When growth hormone pulses are secreted into the systemic circulation, insulinlike growth factor 1 (IGF-1) is released, either locally or at the site of growing bone. Growth hormone binds to a specific growth hormone–binding protein (GHBP) and circulates. This GHBP

2014 eMedicine Pediatrics

133. Growth Hormone Deficiency (Diagnosis)

> Pediatric Growth Hormone Deficiency Updated: Aug 22, 2018 Author: Vaneeta Bamba, MD; Chief Editor: Robert P Hoffman, MD Share Email Print Feedback Close Sections Sections Pediatric Growth Hormone Deficiency Overview Practice Essentials Presentation History The history in patients with suspected growth hormone deficiency (GHD) should focus on the following issues: Birth weight and length: Intrauterine growth retardation is an issue in the differential diagnosis and should be apparent from the birth (...) –releasing peptides (GHRPs). Receptors for the GHRPs have been identified, and the natural ligand for these receptors has been determined to be ghrelin. Somatostatin secreted by the hypothalamus inhibits growth hormone secretion. When growth hormone pulses are secreted into the systemic circulation, insulinlike growth factor 1 (IGF-1) is released, either locally or at the site of growing bone. Growth hormone binds to a specific growth hormone–binding protein (GHBP) and circulates. This GHBP

2014 eMedicine Pediatrics

134. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. (Abstract)

Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. To determine whether the phosphodiesterase type 5 inhibitor, Sildenafil citrate, affects uteroplacental perfusion.Based on a randomized double-blinded and placebo-controlled trial, forty one pregnant women with documented intrauterine growth retardation at 24-37 weeks of gestation were evaluated for the effect of a single dose of Sildenafil citrate on uteroplacental circulation as determined by Doppler ultrasound study (...) [SD 0.60] [95% Cl 0.16-0.85], P=0.008).Doppler velocimetry index values reflect decreased placental bed vascular resistance after Sildenafil. Sildenafil citrate can improve fetoplacental perfusion in pregnancies complicated by intrauterine growth restriction. It could be a potential therapeutic strategy to improve uteroplacental blood flow in pregnancies with fetal growth restriction (FGR).

2013 Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences Controlled trial quality: predicted high

135. Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.

are SGA by customised birthweight curves and non-SGA by population birthweight curves, are not detected antenatally, despite the current strategy including the use of umbilical Doppler. to analyse prenatal care of a subsample of SGA stillbirths with and without detection of FGR by a confidential enquiry. Condition or disease Intervention/treatment Stillbirth Intrauterine Growth Retardation Infant, Small for Gestational Age Other: Antenatal identification of fetal growth restriction Detailed (...) Identifier: Other Study ID Numbers: DCIC12 08 First Posted: November 27, 2013 Last Update Posted: August 4, 2015 Last Verified: December 2014 Keywords provided by University Hospital, Grenoble: Stillbirth Fetal growth restriction Small for gestational age Antenatal detection Prenatal Care Mass Screening Additional relevant MeSH terms: Layout table for MeSH terms Stillbirth Fetal Growth Retardation Fetal Death Pregnancy Complications Death Pathologic Processes Fetal Diseases Growth Disorders

2013 Clinical Trials

136. Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control Study

, Ain Shams Maternity Hospital ClinicalTrials.gov Identifier: Other Study ID Numbers: 11110000 First Posted: November 13, 2013 Last Update Posted: November 13, 2013 Last Verified: October 2013 Keywords provided by Alaa Sayed Abdul-hafeez, Ain Shams Maternity Hospital: prediction IUGR FL/MTC Additional relevant MeSH terms: Layout table for MeSH terms Fetal Growth Retardation Fetal Diseases Pregnancy Complications Growth Disorders Pathologic Processes (...) Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control Study Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2013 Clinical Trials

137. Growth Delay Onset Determination

Determination Growth Delay Onset Determination Aka: Growth Delay Onset Determination From Related Chapters II. Causes: Intrauterine Growth Retardation tic or chromosomal abnormality Transplacental infectious disease ( ) Toxins Nicotine Medications III. Causes: Birth Prolonged Panhypopituitarism IV. Causes: Childhood See Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Growth Delay Onset Determination." Click on the image (or right click (...) Growth Delay Onset Determination Growth Delay Onset Determination Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Growth Delay Onset

2015 FP Notebook

138. Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies

University Study Details Study Description Go to Brief Summary: Intrauterine growth restriction is the term used to describe a condition where an unborn baby does not reach its optimum size. In the short and long term, intrauterine growth restricted babies have a higher risk of serious disease and even death. It is well established that very low levels of oxygen in the baby's blood can harm the baby's health through a state known as oxidative stress. Currently, there is no established treatment available (...) to treat intrauterine growth restriction or its complications. In experimental animal studies however, the naturally occuring hormone, melatonin, has been shown to significantly reduce oxidative stress and improve health of the unborn babies that have suffered from intrauterine growth restriction. This study aims to find out if the use melatonin twice per day throughout pregnancies affected by intrauterine growth restriction will lower the level of oxidative stress experienced by the unborn baby

2012 Clinical Trials

139. A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community

, Simon Fraser University: Air pollution Particulate matter Mongolia Pregnancy Intrauterine growth restriction (IUGR) Fetal growth Birth weight Gestational age Additional relevant MeSH terms: Layout table for MeSH terms Fetal Growth Retardation Fetal Diseases Pregnancy Complications Growth Disorders Pathologic Processes (...) A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2012 Clinical Trials

140. Metabolomic analysis reveals differences in umbilical vein plasma metabolites between normal and growth-restricted fetal pigs during late gestation. Full Text available with Trip Pro

Metabolomic analysis reveals differences in umbilical vein plasma metabolites between normal and growth-restricted fetal pigs during late gestation. Intrauterine growth restriction (IUGR) remains a major problem for both human health and animal production due to its association with high rates of neonatal morbidity and mortality, low efficiency of food utilization, permanent adverse effects on postnatal growth and development, and long-term health and productivity of the offspring. However (...) ) in umbilical vein plasma exhibited a cluster of differences between IUGR and NBW fetuses on d 90 and 110 of gestation. These changes in the IUGR group are associated with disorders of nutrient and energy metabolism as well as endocrine imbalances, which may contribute to the retardation of fetal growth and development. The findings help provide information regarding potential mechanisms responsible for IUGR in swine and also have important implications for the design of effective strategies to prevent

2012 Journal of Nutrition

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>